ReviewFrontiers in pharmacology2026

Interleukin-23 in lung and airway diseases: from pathogenesis to precision-guided therapeutic targeting.

Barsha Baisakhi Nayak et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.